187 related articles for article (PubMed ID: 29169113)
1. A rapid and simple HPLC-MS/MS method for the simultaneous quantification of valproic acid and its five metabolites in human plasma and application to study pharmacokinetic interaction in Chinese epilepsy patients.
Wen D; Chen Z; Yang C; Liu H; Li H; Chen J; Dai Q; Zhong G; Qin J; Ni G; Huang M; Zhou L; Wang X
J Pharm Biomed Anal; 2018 Feb; 149():448-456. PubMed ID: 29169113
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Determination of Valproic Acid and Its Major Metabolites by UHPLC-MS/MS in Chinese Patients: Application to Therapeutic Drug Monitoring.
Zhao M; Zhang T; Li G; Qiu F; Sun Y; Zhao L
J Chromatogr Sci; 2017 Apr; 55(4):436-444. PubMed ID: 27993840
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling.
Xu S; Liu L; Chen Y; Liu M; Lu T; Wang H; Liu S; Zhao M; Zhao L
Eur J Clin Pharmacol; 2018 May; 74(5):583-591. PubMed ID: 29340733
[TBL] [Abstract][Full Text] [Related]
4. Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children.
Liu L; Zhao L; Wang Q; Qiu F; Wu X; Ma Y
Eur J Clin Pharmacol; 2015 Nov; 71(11):1341-7. PubMed ID: 26303110
[TBL] [Abstract][Full Text] [Related]
5. Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy.
Gidal BE; Anderson GD; Rutecki PR; Shaw R; Lanning A
Epilepsy Res; 2000 Nov; 42(1):23-31. PubMed ID: 10996503
[TBL] [Abstract][Full Text] [Related]
6. How to replace lamotrigine with valproate.
Steinhoff BJ
Epilepsia; 2006 Nov; 47(11):1943-4. PubMed ID: 17116036
[TBL] [Abstract][Full Text] [Related]
7. Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children With Epilepsy Comedicated With Lamotrigine.
Wang Q; Zhao L; Liang M; Dong Y; Yun W; Qiu F; Meng H; Guo Y
Ther Drug Monit; 2016 Jun; 38(3):343-9. PubMed ID: 26717295
[TBL] [Abstract][Full Text] [Related]
8. Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography/tandem mass spectrometry.
Kim KB; Seo KA; Kim SE; Bae SK; Kim DH; Shin JG
J Pharm Biomed Anal; 2011 Dec; 56(4):771-7. PubMed ID: 21840666
[TBL] [Abstract][Full Text] [Related]
9. Clinical study of lamotrigine and valproic acid in patients with epilepsy: using a drug interaction to advantage?
Morris RG; Black AB; Lam E; Westley IS
Ther Drug Monit; 2000 Dec; 22(6):656-60. PubMed ID: 11128232
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Simple and Rapid UPLC-MS Assay for Valproic Acid and Its Comparison With Immunoassay and HPLC Methods.
Zhao M; Li G; Qiu F; Sun Y; Xu Y; Zhao L
Ther Drug Monit; 2016 Apr; 38(2):246-52. PubMed ID: 26488205
[TBL] [Abstract][Full Text] [Related]
11. Effect of comedication on lamotrigine clearance in Korean epilepsy patients.
Kim HJ; Kim TE; Joo EY; Seo DW; Lee SY; Hong SB
Clin Chim Acta; 2015 Jan; 438():269-73. PubMed ID: 25218785
[TBL] [Abstract][Full Text] [Related]
12. Influence of concomitant antiepileptic drugs on plasma lamotrigine concentration in adult Japanese epilepsy patients.
Yamamoto Y; Inoue Y; Matsuda K; Takahashi Y; Kagawa Y
Biol Pharm Bull; 2012; 35(4):487-93. PubMed ID: 22466551
[TBL] [Abstract][Full Text] [Related]
13. Comparison of LC-MS/MS vs chemiluminescent microparticle immunoassay in measuring the valproic acid concentration in plasma of epilepsy patients in a new perspective.
Wang Z; Yun Y; Xie X; You C; Miao H; Zhang F; Gao S; Chen W
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28205314
[TBL] [Abstract][Full Text] [Related]
14. Determination of DP-VPA and its active metabolite, VPA, in human plasma, urine, and feces by UPLC-MS/MS: A clinical pharmacokinetics and excretion study.
Li Y; Zhan H; Fan Y; Zhang J; Cao G; Yu J; Chen Y; Guo B
Drug Test Anal; 2019 Jul; 11(7):1035-1047. PubMed ID: 30821115
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication.
May TW; Rambeck B; Jürgens U
Ther Drug Monit; 1996 Oct; 18(5):523-31. PubMed ID: 8885114
[TBL] [Abstract][Full Text] [Related]
16. Determination of lamotrigine in human serum by high-performance liquid chromatography–tandem mass spectrometry.
Lee W; Kim JH; Kim HS; Kwon OH; Lee BI; Heo K
Neurol Sci; 2010 Dec; 31(6):717-20. PubMed ID: 20390433
[TBL] [Abstract][Full Text] [Related]
17. Time course of reversal of valproate-mediated inhibition of lamotrigine.
Leary E; Sheth RD; Gidal BE
Seizure; 2018 Apr; 57():76-79. PubMed ID: 29574285
[TBL] [Abstract][Full Text] [Related]
18. The influence of concomitant antiepileptic drugs on lamotrigine serum concentrations in Northwest Chinese Han population with epilepsy.
Han X; Huang J; Lv J; Ma L; Peng L; Wang J; Nie X; Xia L; Zan X
PLoS One; 2019; 14(1):e0210600. PubMed ID: 30645607
[TBL] [Abstract][Full Text] [Related]
19. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S
Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151
[TBL] [Abstract][Full Text] [Related]
20. The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy.
Gulcebi MI; Ozkaynakcı A; Goren MZ; Aker RG; Ozkara C; Onat FY
Epilepsy Res; 2011 Jun; 95(1-2):1-8. PubMed ID: 21601426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
